Characteristics of chronic myeloid leukemia patients achieving deep molecular response in Vietnam. [PDF]
Dung PC+9 more
europepmc +1 more source
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies. [PDF]
Sicuranza A+26 more
europepmc +1 more source
Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results. [PDF]
Cortes JE+17 more
europepmc +1 more source
The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers. [PDF]
Sicuranza A, Cavalleri A, Bernardi S.
europepmc +1 more source
Neoadjuvant Imatinib in Recurrent/Metastatic Gastrointestinal Stromal Tumors: A Systematic Review and Meta-analysis of Proportions. [PDF]
Stavrou N+6 more
europepmc +1 more source
Tenascin-C Facilitates Microglial Polarization via TLR4/MyD88/NF-κB Pathway Following Subarachnoid Hemorrhage. [PDF]
Hu ZQ+7 more
europepmc +1 more source
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial. [PDF]
Yip D+14 more
europepmc +1 more source
Extra-gastrointestinal Stromal Tumor of the Urinary Bladder: A Report of a Rare Case and Literature Review. [PDF]
Kushwaha SS, Goyal A, Goja S.
europepmc +1 more source
Staged carotid artery stenting for nilotinib-induced cervical internal carotid artery stenosis: illustrative case. [PDF]
Kushino K+8 more
europepmc +1 more source